From Copper By-Product to Strategic Asset: Two Forces Fueling Molybdenum’s 50% Rally

Powerful Profit Engines and Reasonable Valuations Make Alphabet and Amazon Suitable for Long-Term Investors

Technology

The $10 Billion Acquisition Is Set, as Vertex Pharmaceuticals Bets on a New Blue Ocean in Rare Endocrine Diseases

Life Science

Anthropic Nears IPO, Investors Seek Early Entry Points

Technology

These Three Tech and Industrial Leaders Are Poised to Hit the Trillion-Dollar Mark Before Palantir

Technology

AI Cloud Business Grows at an Alarming Rate, While Oracle’s Heavy Debt Burden Raises Concerns

Technology

Three Biotech Stocks Crushed the S&P 500 — Analysts Still Back Just One

Life Science

Bridging the Security Gap, NVIDIA and Palantir Co-Launch a New Federated AI Architecture

Technology

Employment and Inflation Drive Sentiment as Bitcoin Hovers Near Key Resistance Level Awaiting Breakthrough

Cryptocurrency, Technology

Meta’s Cloud Pivot: Value Trap or Hidden Gold Mine?

Technology

After a 120% Surge, This AI Memory ETF Is Counting on SK Hynix’s IPO to Reignite the Rally

Technology

Lithium’s New Rally: Same Surge, Different Story

Energy Metals

Marvell and Micron: Can These AI Chip Stocks Still Be Chased after Triple-Digit Surges?

Technology

Triple-Digit Gains Haven’t Killed This Biotech’s Upside. Here’s What Comes Next

Life Science

AMD and Intel Crushed Nvidia in the First Half. Will the Story Reverse in the Second Half?

Technology